June 25, 2020
Aadi Bioscience Initiates Rolling Submission of NDA to FDA for nab-sirolimus (ABI-009, FYARRO™) for the Treatment of Advanced Malignant PEComa
Rolling submission of U.S. FDA New Drug Application initiated Long-term follow-up data released at ASCO 2020 for AMPECT study Independent…